REDESCA
REDESCA
Approved
DIN Number
02509113
Drug Class
Human
Market Date
Apr 9, 2021
Company
HC
Shenzhen Techdow Pharmaceutical Co., Ltd.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02509113
AIG Number0131860001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AB05 ENOXAPARIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
,
Subcutaneous
AHFS Classification20:12.04.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
ENOXAPARIN SODIUMActive
Strength: 100 MG / ML
Monograph: ENOXAPARIN SODIUM